157 related articles for article (PubMed ID: 12690409)
1. [Mechanism of action of lithium: intracellular signaling pathways].
Zorrilla Zubilete M
Vertex; 2003; 14(51):45-52. PubMed ID: 12690409
[TBL] [Abstract][Full Text] [Related]
2. Anti-bipolar therapy: mechanism of action of lithium.
Jope RS
Mol Psychiatry; 1999 Mar; 4(2):117-28. PubMed ID: 10208444
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
Gould TD; Zarate CA; Manji HK
J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
[TBL] [Abstract][Full Text] [Related]
4. Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder.
Shamir A; Elhadad N; Belmaker RH; Agam G
Bipolar Disord; 2005 Feb; 7(1):42-8. PubMed ID: 15654931
[TBL] [Abstract][Full Text] [Related]
5. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
6. Calcium dysregulation, and lithium treatment to forestall Alzheimer's disease - a merging of hypotheses.
Wallace J
Cell Calcium; 2014 Mar; 55(3):175-81. PubMed ID: 24636273
[TBL] [Abstract][Full Text] [Related]
7. Inositol monophosphatase, the putative therapeutic target for lithium.
Atack JR
Brain Res Brain Res Rev; 1996 Aug; 22(2):183-90. PubMed ID: 8883919
[TBL] [Abstract][Full Text] [Related]
8. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
9. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
10. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
11. Biological predictors of lithium response in bipolar disorder.
Ikeda A; Kato T
Psychiatry Clin Neurosci; 2003 Jun; 57(3):243-50. PubMed ID: 12753562
[TBL] [Abstract][Full Text] [Related]
12. Review of lithium effects on brain and blood.
Young W
Cell Transplant; 2009; 18(9):951-75. PubMed ID: 19523343
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets of lithium action.
Phiel CJ; Klein PS
Annu Rev Pharmacol Toxicol; 2001; 41():789-813. PubMed ID: 11264477
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glycogen synthase kinase-3 in patients with affective disorders.
O'Brien WT; Klein PS
Biol Psychiatry; 2007 Jan; 61(2):139-41. PubMed ID: 17223440
[No Abstract] [Full Text] [Related]
15. Validating GSK3 as an in vivo target of lithium action.
O'Brien WT; Klein PS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1133-8. PubMed ID: 19754466
[TBL] [Abstract][Full Text] [Related]
16. Lithium and Therapeutic Targeting of GSK-3.
Snitow ME; Bhansali RS; Klein PS
Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
[TBL] [Abstract][Full Text] [Related]
17. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
[TBL] [Abstract][Full Text] [Related]
18. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs.
Agam G; Shamir A; Shaltiel G; Greenberg ML
Bipolar Disord; 2002; 4 Suppl 1():15-20. PubMed ID: 12479670
[TBL] [Abstract][Full Text] [Related]
19. Lithium: underappreciated and underused?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2007 Aug; 45(8):13-7. PubMed ID: 17848039
[TBL] [Abstract][Full Text] [Related]
20. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
Gurvich N; Klein PS
Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
